Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1293-1298, doi:10.1016/j.jacc.2008.07.026
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related CVN News Brief on Cardiosource
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stabile, E.
Right arrow Articles by Rubino, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stabile, E.
Right arrow Articles by Rubino, P.
Related Collections
Right arrowRelated Articles

The CIAO (Coronary Interventions Antiplatelet-based Only) Study

A Randomized Study Comparing Standard Anticoagulation Regimen to Absence of Anticoagulation for Elective Percutaneous Coronary Intervention

Eugenio Stabile, MD, PhD, FESC, FAHA*,*, Wail Nammas, MD*, Luigi Salemme, MD*, Giovanni Sorropago, MD*, Angelo Cioppa, MD*, Tullio Tesorio, MD*, Vittorio Ambrosini, MD*, Esther Campopiano, MD*, Gregory Popusoi, MD*, Giuseppe Biondi Zoccai, MD{dagger} and Paolo Rubino, MD*

* Laboratory of Invasive Cardiology, Division of Cardiology, Clinica Montevergine, Mercogliano, Italy
{dagger} Interventional Cardiology, Division of Cardiology, S. Giovanni Battista-Molinette Hospital, University of Turin, Turin, Italy


Figure 1
View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Post-Procedural Myocardial Damage

Creatine kinase-myocardial band (CK-MB) release after percutaneous coronary intervention (PCI) in patients receiving standard anticoagulation therapy (heparin; purple bars) and in patients receiving no anticoagulation therapy (placebo; hatched bars) (p = 0.034).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement